76 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
, or the Securities Exchange Act of 1934, as amended.
The primary purpose of the Audit Committee is to oversee our financial reporting processes … options for the purpose of computing the percentage ownership of that person, but are not treated as outstanding for the purpose of computing
S-8
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Registration of securities for employees
4:34pm
) solely for the purpose of calculating the registration fee on the basis of $17.17 per share, which is the average of the high and low prices of Common
S-8
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Registration of securities for employees
4:34pm
Exchange Act of 1934, as amended (the “Exchange Act”), on September 13, 2023 including any amendments or reports filed for the purpose of updating
10-K
y89mbej4mpv90y
7 Mar 24
Annual report
4:05pm
10-K
EX-10.23
sgsntk xz96v995ofc
7 Mar 24
Annual report
4:05pm
10-K
EX-10.22
3vapwjew3 ttrf
7 Mar 24
Annual report
4:05pm
10-K
EX-97.1
mwz c3swuw1uanw
7 Mar 24
Annual report
4:05pm
S-8
EX-99.4
2tmto d2gaw8ayz
19 Sep 23
Registration of securities for employees
9:57pm
S-8
EX-99.3
4xazibwaa
19 Sep 23
Registration of securities for employees
9:57pm
S-8
vfoiwphclf8o45z8
19 Sep 23
Registration of securities for employees
9:57pm
S-8
EX-99.1
xyu2qtlv1m3rcw765j
19 Sep 23
Registration of securities for employees
9:57pm
S-8
meqg ag08vlkip853my
19 Sep 23
Registration of securities for employees
9:57pm
8-K
EX-3.2
1dv8e9a
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
EX-3.1
b815e
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
pko49gv iu
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
bts1qd
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-1.1
t25sa up1r
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
f5g8u9c8r9r00xanc7w
11 Sep 23
IPO registration (amended)
6:07am